TherapeuticsMD, Inc. (TXMD)

NASDAQ: TXMD · IEX Real-Time Price · USD
+0.25 (6.02%)
At close: Jun 2, 2023, 4:00 PM
-0.05 (-1.14%)
After-hours: Jun 2, 2023, 4:07 PM EDT

Total Valuation

TherapeuticsMD has a market cap or net worth of $45.16 million. The enterprise value is $33.71 million.

Market Cap 45.16M
Enterprise Value 33.71M

Important Dates

The last earnings date was Monday, May 15, 2023, after market close.

Earnings Date May 15, 2023
Ex-Dividend Date n/a

Share Statistics

TherapeuticsMD has 10.26 million shares outstanding. The number of shares has increased by 13.23% in one year.

Shares Outstanding 10.26M
Shares Change (YoY) +13.23%
Shares Change (QoQ) -0.96%
Owned by Insiders (%) 6.37%
Owned by Institutions (%) 45.09%
Float 7.67M

Valuation Ratios

The trailing PE ratio is 0.25 and the forward PE ratio is 2.29. TherapeuticsMD's PEG ratio is -0.73.

PE Ratio 0.25
Forward PE 2.29
PS Ratio 0.86
Forward PS 5.64
PB Ratio 1.37
P/FCF Ratio n/a
PEG Ratio -0.73
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.21
EV / Sales 0.66
EV / EBITDA 0.24
EV / EBIT 0.24
EV / FCF n/a

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.22.

Current Ratio 1.28
Quick Ratio 1.00
Debt / Equity 0.22
Debt / EBITDA 0.05
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -8,781.90% and return on invested capital (ROIC) is 7,905.70%.

Return on Equity (ROE) -8,781.90%
Return on Assets (ROA) 146.40%
Return on Capital (ROIC) 7,905.70%
Revenue Per Employee $51.05M
Profits Per Employee $157.42M
Employee Count 1
Asset Turnover 0.48
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.25% in the last 52 weeks. The beta is 1.17, so TherapeuticsMD's price volatility has been higher than the market average.

Beta (1Y) 1.17
52-Week Price Change -58.25%
50-Day Moving Average 3.84
200-Day Moving Average 5.55
Average Volume (30 Days) 38,806

Short Selling Information

The latest short interest is 312,546, so 3.05% of the outstanding shares have been sold short.

Short Interest 312,546
Short Previous Month 342,345
Short % of Shares Out 3.05%
Short % of Float 4.08%
Short Ratio (days to cover) 6.13

Income Statement

In the last 12 months, TherapeuticsMD had revenue of $51.05 million and earned $157.42 million in profits. Earnings per share was $17.12.

Revenue 51.05M
Gross Profit 54.51M
Operating Income 24.75M
Pretax Income 157.42M
Net Income 157.42M
EBITDA 143.17M
EBIT 143.05M
Earnings Per Share (EPS) $17.12
Full Income Statement

Balance Sheet

The company has $17.25 million in cash and $7.14 million in debt, giving a net cash position of $10.11 million or $0.99 per share.

Cash & Cash Equivalents 17.25M
Total Debt 7.14M
Net Cash 10.11M
Net Cash Per Share $0.99
Equity / Book Value 32.02M
Book Value Per Share 3.12
Working Capital 5.40M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.73 million and capital expenditures $42,000, giving a free cash flow of -$7.69 million.

Operating Cash Flow -7.73M
Capital Expenditures 42,000
Free Cash Flow -7.69M
FCF Per Share -$0.79
Full Cash Flow Statement


Gross margin is 106.78%, with operating and profit margins of 48.49% and 308.38%.

Gross Margin 106.78%
Operating Margin 48.49%
Pretax Margin 308.38%
Profit Margin 308.38%
EBITDA Margin 280.48%
EBIT Margin 280.24%
FCF Margin -15.06%

Dividends & Yields

TherapeuticsMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield 359.22%
FCF Yield -17.54%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -13.23%
Shareholder Yield -13.23%
Dividend Details

Analyst Forecast

The average price target for TherapeuticsMD is $7.50, which is 70.46% higher than the current price. The consensus rating is "Hold".

Price Target $7.50
Price Target Difference 70.46%
Analyst Consensus Hold
Analyst Count 2
Revenue Growth Forecast (5Y) -35.43%
EPS Growth Forecast (5Y) -58.75%
Stock Forecasts

Stock Splits

The last stock split was on May 9, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date May 9, 2022
Split Type Reverse
Split Ratio 1:50